Allergan Inc (AGN)

AGN (NYSE:Drugs) EQUITY
$240.22
pos +2.88
+1.21%
Today's Range: 237.72 - 241.78 | AGN Avg Daily Volume: 2,195,100
Last Update: 03/16/15 - 4:03 PM EDT
Volume: 7,503,601
YTD Performance: 13.00%
Open: $238.89
Previous Close: $237.34
52 Week Range: $115.94 - $237.88
Oustanding Shares: 300,237,694
Market Cap: 72,123,098,853
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 3 4 4
Moderate Buy 0 0 0 0
Hold 11 11 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.47 2.57 2.43 2.43
Latest Dividend: 0.05
Latest Dividend Yield: 0.08%
Dividend Ex-Date: 02/25/15
Price Earnings Ratio: 47.18
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
47.18 47.90 27.68
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
16.75% 87.17% 158.30%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.90 0.34 0.10
Net Income 54.60 0.63 0.18
EPS 54.60 0.67 0.18
Earnings for AGN:
EBITDA 2.49B
Revenue 7.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $1.79 $2.14 $8.58 $10.45
Number of Analysts 4 4 13 11
High Estimate $1.84 $2.20 $8.86 $11.65
Low Estimate $1.76 $2.11 $8.33 $9.91
Prior Year $1.18 $1.51 $6.65 $8.58
Growth Rate (Year over Year) 51.69% 41.89% 29.08% 21.75%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 11, 2015 | 2:40 PM EDT

Don't get me started ... wait, DO get me started.

By

Jim Cramer

 | Apr 9, 2015 | 1:58 PM EDT

These companies are the hottest thing going.

By

Jim Cramer

 | Mar 31, 2015 | 11:33 AM EDT

Combined Heinz-Kraft heads a long second-quarter list.

By

Jim Cramer

 | Mar 2, 2015 | 3:45 PM EST

It's almost comical how welcoming it is these days.

By

Jim Cramer

 | Feb 23, 2015 | 11:59 AM EST

It is no pipedream that the stock could trade to $240.

By

Jim Cramer

 | Feb 17, 2015 | 5:44 AM EST

The two apparent failures are in fact opportunities.

bearishAllergan downgraded at BTIG

Jan 8, 2015 | 7:41 AM EST

AGN was downgraded from Buy to Neutral, BTIG said. Do not expect another takeover bid to materialize. 

By

Herb Greenberg

 | Dec 9, 2014 | 11:10 AM EST

Has the pharmaceutical company really changed its strategy?

By

Jim Cramer

 | Dec 3, 2014 | 3:59 PM EST

An immense market rotation is happening.

By

Jim Cramer

 | Nov 24, 2014 | 4:12 PM EST

This market provides a slew of reasons to buy right now.

General Electric (GE) shares have underperformed relative to the S&P 500 index for the...

There is $1.25 billion to sell market on close as of 347PM.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.